American Stroke Association issues 2024 guideline on primary prevention of stroke
The American Stroke Association’s 2024 guideline for the primary prevention of stroke updates clinical recommendations to reduce first-stroke risk through screening, lifestyle change, and targeted treatments.
The American Stroke Association has released the 2024 Guideline for the Primary Prevention of Stroke, published in the journal Stroke, replacing the association’s 2014 guidance and updating prevention strategies for people with no prior stroke. The guideline stresses that primary prevention of stroke should start in primary care, relying on routine screening, risk assessment and evidence-based interventions to lower the chance of a first stroke. It emphasizes lifestyle measures, targeted medication when indicated, new risk-assessment tools and attention to social and sex- and gender-specific factors that influence stroke risk.
Scope and rationale for the 2024 update
The guideline replaces a decade-old framework and incorporates new clinical evidence and public health priorities since 2014.
Stroke remains a leading cause of death and disability in the United States; estimates show more than 600,000 first strokes occur annually and roughly 80% of strokes are preventable with timely interventions.
Authors note that earlier detection and management of cardiovascular risk factors can prevent arterial damage to the brain and heart long before clinical events occur, underscoring the need for lifelong prevention starting in young adulthood.
Risk identification and new tools for clinicians
The guideline recommends routine screening for modifiable risk factors such as hypertension, elevated cholesterol, obesity and elevated blood glucose in primary care settings.
It highlights a new risk-prediction resource, the PREVENT calculator, which estimates 10- and 30-year risk for stroke and cardiovascular events beginning at age 30, enabling earlier intervention than prior calculators.
Clinicians are advised to use validated risk tools to guide discussions about preventive therapies and to tailor interventions to individual risk profiles.
Lifestyle measures emphasized as foundational prevention
Healthy behaviors are central to the guideline’s recommendations, reflecting the association’s Life’s Essential 8 metrics: healthy nutrition, physical activity, avoidance of tobacco, healthy sleep and weight, and control of cholesterol, blood pressure and blood sugar.
The document recommends a Mediterranean-style dietary pattern—especially when supplemented with nuts and olive oil—as part of stroke risk reduction strategies, and it endorses established physical activity targets of at least 150 minutes of moderate or 75 minutes of vigorous aerobic activity weekly.
Providers are urged to screen for sedentary behavior and to counsel patients on structured, achievable lifestyle plans that can be reinforced over time.
Medication options and emerging pharmacologic guidance
For patients with identified risk factors, the guideline supports pharmacologic treatment when clinically indicated, including antihypertensives to lower blood pressure and statins to reduce cholesterol-related risk.
A notable addition is the consideration of glucagon-like peptide-1 (GLP-1) receptor agonists for people with overweight or obesity and/or type 2 diabetes, reflecting recent evidence that these agents can reduce cardiovascular risk in selected patients.
The guideline stresses that medication decisions should be individualized, balancing potential benefits with cost, accessibility and patient preferences.
Addressing sex, gender and pregnancy-related risks
The 2024 guidance introduces specific recommendations to screen and manage conditions that raise stroke risk in women, including use of combined oral contraceptives, hypertensive disorders of pregnancy, premature birth and other pregnancy complications.
It calls for proactive treatment of elevated blood pressure during pregnancy and in the postpartum period—particularly within six weeks after delivery—to reduce the risk of maternal intracerebral hemorrhage.
The committee also highlights the need to evaluate and manage stroke risk in transgender women and gender-diverse individuals using estrogen therapies, recommending modification of modifiable risk factors where present.
Health equity, social determinants and access to care
A new focus in the guideline is the impact of social determinants of health—such as education, economic stability, access to healthy food, neighborhood infrastructure and discrimination—on stroke risk and prevention.
The document advises clinicians to provide education tailored to varying literacy and language needs, to consider affordability when selecting treatments, and to connect patients with community resources addressing food, housing and medication access.
Addressing structural barriers and advocating for more equitable systems of care are presented as essential steps to reduce disparities in stroke incidence and outcomes.
The writing group, led by Cheryl D. Bushnell, M.D., M.H.S., FAHA, notes limitations in the evidence base—particularly the relative paucity of primary prevention trials in younger, diverse populations—and calls for research to fill gaps identified in the guideline. The authors also link stroke prevention to reduced dementia risk, reinforcing the broader cognitive benefits of vascular health interventions.
The guideline underscores that many prevention strategies are low-tech, evidence-based actions that primary care teams can implement immediately: screen for risk factors, counsel on diet and activity, optimize blood pressure and cholesterol management, and use risk calculators to inform shared decision-making. Public and clinical adoption of these recommendations aims to lower the incidence of first stroke and its associated disability across the population.
Learning the warning signs of stroke and acting quickly remains critical; the guideline reiterates public education on the F.A.S.T. signs—face drooping, arm weakness, speech difficulty—and the need to call emergency services without delay when symptoms appear.
